54 Results for "

AMPA Receptor Modulator

" in MedChemExpress (MCE) Product Catalog:
Products (54)

54 Results for "AMPA Receptor Modulator" in MCE Product Catalog:

Cat. No.: HY-P3355
CAS No.: 2883747-74-6
Target:  

iGluR

Research Areas:  

Neurological Disease

p-fin4 is a peptide inhibitor of STEP Phosphatase-GluA2 AMPA receptor interaction with a Ki of 0.4 μM. p-fin4 restores the memory deficits and displays anxiolytic and antidepressant effects in a scopolamine-treated rat model. p-fin4 is a promising lead compound for novel cognitive enhancers and/or behavioral modulators .
loading...
    loading...
Cat. No.: HY-P3354
Target:  

iGluR

Research Areas:  

Neurological Disease

p3Ysh-3 is a peptide inhibitor of STEP Phosphatase-GluA2 AMPA receptor interaction with a Ki of 1.09 μM. p3Ysh-3 restores the memory deficits and displays anxiolytic and antidepressant effects in a scopolamine-treated rat model. p3Ysh-3 is a promising lead compound for novel cognitive enhancers and/or behavioral modulators .
loading...
    loading...
Cat. No.: HY-168966
CAS No.: 2097493-39-3
Research Areas:  

Neurological Disease

JNJ-54082730 (Compound 1) is the orally active inhibitor for phosphodiesterase (PDE) that inhibits PDE2A, PDE3B, and PDE10A2 with IC50s of 0.95 nM, 6.17 μM (pIC50=5.21) and 87.1 nM (pIC50=7.06), respectively. JNJ-54082730 modulates the activity of AMPA receptor, enhance the synaptic plasticity and promotes the learning and memory function in rats models. JNJ-54082730 can cross blood-brain barrier .
loading...
    loading...
Cat. No.: HY-10933R
CAS No.: 154235-83-3
Synonyms: BDP 12 (Standard)
Research Areas:  

Neurological Disease

CX516 (Standard) is the analytical standard of CX516 (HY-10933). This product is intended for research and analytical applications. CX516 (BDP 12) is an ampaKine and acts as an AMPA receptor positive allosteric modulator for the research of Alzheimer's disease, schizophrenia and mild cognitive impairment (MCI) .
loading...
    loading...
Cat. No.: HY-187700
Research Areas:  

Neurological Disease

BRD3290 is a GluA3-preferring AMPA receptor positive allosteric modulator with brain exposure in Mus musculus (mice) following peripheral administration. BRD3290 preferentially potentiates GluA3-containing AMPA receptors over GluA1/2-containing AMPA receptors. BRD3290 increases cerebellar cGMP levels in Mus musculus (mice). BRD3290 does not induce convulsions, alter motor function, or improve novel object recognition task performance in Mus musculus (mice) at tested doses. BRD3290 can be used for the research of schizophrenia .
loading...
    loading...
Cat. No.: HY-101216R
CAS No.: 100044-96-0
Research Areas:  

Neurological Disease

Org-26576 (Standard) is the analytical standard of Org-26576 (HY-101216). This product is intended for research and analytical applications. Org-26576 is a AMPA receptor positive allosteric modulator.
loading...
    loading...
Cat. No.: HY-10937R
CAS No.: 211735-76-1
Synonyms: CX-691 (Standard); Org24448 (Standard)
Research Areas:  

Neurological Disease

Farampator (Standard) is the analytical standard of Farampator (HY-10937). This product is intended for research and analytical applications. Farampator (CX-691;Org24448) is an AMPA receptor positive modulator.
loading...
    loading...
Cat. No.: HY-186183
CAS No.: 3080492-21-0
Normethyl-ZCAN262 (Normethyl-262) is a blood-brain barrier-permeable selective GluR2/AMPAR receptor modulator. Normethyl-ZCAN262 inhibits AMPA-mediated neurotoxicity, the formation of the GAPDH-GluR2 complex, and GluR2/AMPAR neurotoxicity. Normethyl-ZCAN262 enables in vivo imaging of brain AMPA receptors and is used in research related to multiple sclerosis, amyotrophic lateral sclerosis, neuroinflammation, stroke, epilepsy, Parkinson's disease, Alzheimer's disease, dementia, and Huntington's disease .
loading...
    loading...
Cat. No.: HY-165474
CAS No.: 2231103-08-3
Target:  

iGluR

Research Areas:  

Neurological Disease

TDPAM01 is a positive allosteric modulator of AMPA receptor GluA2. TDPAM01 can specifically bind to the ligand-binding domain (LBD) of GluA2 and shows an IC50 of 13.4 nM for the GluA2 flop subtype. TDPAM01 can stabilize the activated conformation of GluA2 receptors, delay the receptor deactivation or desensitization process, maintaining the rapid excitatory synaptic transmission in the central nervous system .
loading...
    loading...
Cat. No.: HY-165475
CAS No.: 2231101-34-9
Target:  

iGluR

Research Areas:  

Neurological Disease

TDPAM02 is a positive allosteric modulator of AMPA receptor GluA2. TDPAM02 can specifically bind to the ligand-binding domain (LBD) of GluA2 and shows an IC50 of 1.4 nM for the GluA2 flop subtype. TDPAM02 can stabilize the activated conformation of GluA2 receptors, delay the receptor deactivation or desensitization process, maintaining the rapid excitatory synaptic transmission in the central nervous system .
loading...
    loading...
Cat. No.: HY-101528R
CAS No.: 22503-72-6
Research Areas:  

Neurological Disease

IDRA 21 (Standard) is the analytical standard of IDRA 21 (HY-101528). This product is intended for research and analytical applications. IDRA 21 is a positive and orally active modulator of the AMPA receptor. IDRA 21 facilitates excitatory neurotransmission via GluR1/2 receptors. IDRA 21 has the potential for the research of cognitive/memory disorders, including those associated with aging .
loading...
    loading...
Cat. No.: HY-109046R
CAS No.: 1038984-31-4
Synonyms: CX-1632 (Standard); S-47445 (Standard)
Research Areas:  

Neurological Disease

Tulrampator (Standard) is the analytical standard of Tulrampator (HY-109046). This product is intended for research and analytical applications. Tulrampator (S-47445) is an orally active selective AMPA receptor modulator. Tulrampator possesses procognitive, enhancing synaptic plasticity, anti-depressant-anxiolytic-like, procognitive and potential neuroprotective properties. Tulrampator can be used for research of alzheimer’s disease and in major depressive disorder .
loading...
    loading...
Cat. No.: HY-10936R
CAS No.: 175340-20-2
Research Areas:  

Neurological Disease

S 18986 (Standard) is the analytical standard of S 18986 (HY-10936). This product is intended for research and analytical applications. S 18986 is a selective, orally active, brain penetrant positive allosteric modulator of AMPA-type receptors. S 18986 shows cognitive enhancing properties in rodents. S 18986 activates the release of noradrenaline and acetylcholine in rat hippocampus and enhances rat memory in object-recognition tests .
loading...
    loading...
Cat. No.: HY-110175R
CAS No.: 191744-13-5
Research Areas:  

Neurological Disease

CX614 (Standard) is the analytical standard of CX614 (HY-110175). This product is intended for research and analytical applications. CX614 is a positive variant modulator of AMPA receptors that enhances excitatory postsynaptic potentials (amplitude and duration) by blocKing and slowing the inactivation of responses to glutamate and automatically evokes excitatory postsynaptic currents in neuronal cultures. CX614 can be used in the study of psychiatric disorders such as depression .
loading...
    loading...